Literature DB >> 16040326

Vaginal Candida parapsilosis: pathogen or bystander?

Paul Nyirjesy1, Alynn B Alexander, M Velma Weitz.   

Abstract

OBJECTIVE: Candida parapsilosis is an infrequent isolate on vaginal cultures; its role as a vaginal pathogen remains unstudied. This retrospective study of women with positive culture for C. parapsilosis sought to characterize the significance of this finding and its response to antifungal therapy.
METHODS: From February 2001 to August 2002, we identified all individuals with positive fungal isolates among a population of women with chronic vulvovaginal symptoms. Charts of women with C. parapsilosis cultures were reviewed with regard to patient demographics, clinical presentation and therapeutic response. Mycological cure, defined as a negative fungal culture at the next office visit, and clinical cure, i.e. symptom resolution, were determined for each subject.
RESULTS: A total of 582 women had positive vaginal cultures for 635 isolates, of which 54 (8.5%) were C. parapsilosis. The charts of 51 subjects with C. parapsilosis were available for review and follow-up cultures and clinical information were available for 39 (76.5%). Microscopy was positive in 9 (17.6%). Antifungal treatment resulted in mycological cure in 17/19 patients with fluconazole, 7/7 with butoconazole, 6/6 with boric acid, 1/1 with miconazole and occurred spontaneously in 6/7: 24/37 (64.9%) patients with a mycological cure experienced clinical cure.
CONCLUSIONS: Although C. parapsilosis is often a cause of vaginal symptoms, it seems to respond to a variety of antifungal agents and may even be a transient vaginal colonizer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040326      PMCID: PMC1784559          DOI: 10.1080/10647440400025603

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  11 in total

1.  Management of recurrent vulvovaginal candidiasis: unresolved issues.

Authors:  Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

2.  Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights.

Authors:  Melissa A Kennedy; Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

3.  The Role of PCR in the Diagnosis of Candida Vulvovaginitis-a New Gold Standard?

Authors:  J D Sobel; Robert A Akins
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

4.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

Review 5.  Candida parapsilosis Vaginal Infection-a New Site of Azole Drug Resistance.

Authors:  J D Sobel; S Suprapaneni
Journal:  Curr Infect Dis Rep       Date:  2018-08-27       Impact factor: 3.725

6.  Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Authors:  Alex Farr; Isaak Effendy; Brigitte Frey Tirri; Herbert Hof; Peter Mayser; Ljubomir Petricevic; Markus Ruhnke; Martin Schaller; Axel P A Schäfer; Birgit Willinger; Werner Mendling
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

7.  Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.

Authors:  Yuxia Zhu; Yingying Shan; Shangrong Fan; Jianling Li; Xiaoping Liu
Journal:  Mycopathologia       Date:  2014-10-17       Impact factor: 2.574

Review 8.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates.

Authors:  Ahmet Bariş Güzel; Merve Aydın; Melda Meral; Ayşe Kalkancı; Macit Ilkit
Journal:  Infect Dis Obstet Gynecol       Date:  2013-12-11

10.  Prevalence of Candida spp. and age-related disparities amongst women presenting with vaginitis at the Obstetrics and Gynaecology (O&G) Clinic in a Tertiary hospital in Port Harcourt, Nigeria.

Authors:  Chiaka Mbakwem-Aniebo; Anwuli Uche Osadebe; Eunice Athanasonny; Iheanyi Omezurike Okonko
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.